These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 34944843)

  • 21. Methylated circulating tumor DNA in blood: power in cancer prognosis and response.
    Warton K; Mahon KL; Samimi G
    Endocr Relat Cancer; 2016 Mar; 23(3):R157-71. PubMed ID: 26764421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA methylation regulates TIGIT expression within the melanoma microenvironment, is prognostic for overall survival, and predicts progression-free survival in patients treated with anti-PD-1 immunotherapy.
    Niebel D; Fröhlich A; Zarbl R; Fietz S; de Vos L; Vogt TJ; Dietrich J; Sirokay J; Kuster P; Saavedra G; Ramírez Valladolid S; Hoffmann F; Strieth S; Landsberg J; Dietrich D
    Clin Epigenetics; 2022 Apr; 14(1):50. PubMed ID: 35410311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extracellular vesicles as a liquid biopsy for melanoma: Are we there yet?
    Medhin LB; Beasley AB; Warburton L; Amanuel B; Gray ES
    Semin Cancer Biol; 2023 Feb; 89():92-98. PubMed ID: 36706847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrated differential DNA methylation and gene expression of formalin-fixed paraffin-embedded uveal melanoma specimens identifies genes associated with early metastasis and poor prognosis.
    Ness C; Katta K; Garred Ø; Kumar T; Olstad OK; Petrovski G; Moe MC; Noer A
    Exp Eye Res; 2021 Feb; 203():108426. PubMed ID: 33387485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genome-wide methylation profiling of glioblastoma cell-derived extracellular vesicle DNA allows tumor classification.
    Maire CL; Fuh MM; Kaulich K; Fita KD; Stevic I; Heiland DH; Welsh JA; Jones JC; Görgens A; Ricklefs T; Dührsen L; Sauvigny T; Joosse SA; Reifenberger G; Pantel K; Glatzel M; Miklosi AG; Felce JH; Caselli M; Pereno V; Reimer R; Schlüter H; Westphal M; Schüller U; Lamszus K; Ricklefs FL
    Neuro Oncol; 2021 Jul; 23(7):1087-1099. PubMed ID: 33508126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liquid biomarkers in melanoma: detection and discovery.
    Lim SY; Lee JH; Diefenbach RJ; Kefford RF; Rizos H
    Mol Cancer; 2018 Jan; 17(1):8. PubMed ID: 29343260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liquid biopsy in CNS tumors: Current status & future perspectives.
    Husain N; Husain A; Mishra S; Srivastava P
    Indian J Pathol Microbiol; 2022 May; 65(Supplement):S111-S121. PubMed ID: 35562141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel DNA methylation markers with potential prognostic relevance in advanced malignant melanoma identified using COBRA assays.
    Kaehler KC; Politz O; Henderson D; Ulbrich HF; Hauschild A; Mund C; Egberts F
    Melanoma Res; 2015 Jun; 25(3):225-31. PubMed ID: 25919928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The potential of liquid biopsy in the management of cancer patients.
    Markou A; Tzanikou E; Lianidou E
    Semin Cancer Biol; 2022 Sep; 84():69-79. PubMed ID: 35331850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liquid biopsy in ovarian cancer: the potential of circulating miRNAs and exosomes.
    Giannopoulou L; Zavridou M; Kasimir-Bauer S; Lianidou ES
    Transl Res; 2019 Mar; 205():77-91. PubMed ID: 30391474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biomarkers for personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2015 Mar; 64(3 Suppl 1):S16-21. PubMed ID: 25468140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metastatic Melanoma: Liquid Biopsy as a New Precision Medicine Approach.
    Ricciardi E; Giordani E; Ziccheddu G; Falcone I; Giacomini P; Fanciulli M; Russillo M; Cerro M; Ciliberto G; Morrone A; Guerrisi A; Valenti F
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor mutation burden and circulating tumor DNA in combined CTLA-4 and PD-1 antibody therapy in metastatic melanoma - results of a prospective biomarker study.
    Forschner A; Battke F; Hadaschik D; Schulze M; Weißgraeber S; Han CT; Kopp M; Frick M; Klumpp B; Tietze N; Amaral T; Martus P; Sinnberg T; Eigentler T; Keim U; Garbe C; Döcker D; Biskup S
    J Immunother Cancer; 2019 Jul; 7(1):180. PubMed ID: 31300034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic biomarkers in skin cancer.
    Greenberg ES; Chong KK; Huynh KT; Tanaka R; Hoon DS
    Cancer Lett; 2014 Jan; 342(2):170-7. PubMed ID: 22289720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Making the Rounds: Exploring the Role of Circulating Tumor DNA (ctDNA) in Non-Small Cell Lung Cancer.
    Shields MD; Chen K; Dutcher G; Patel I; Pellini B
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using Circulating Tumor DNA in Colorectal Cancer: Current and Evolving Practices.
    Malla M; Loree JM; Kasi PM; Parikh AR
    J Clin Oncol; 2022 Aug; 40(24):2846-2857. PubMed ID: 35839443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The potential of ctDNA analysis in breast cancer.
    Tzanikou E; Lianidou E
    Crit Rev Clin Lab Sci; 2020 Jan; 57(1):54-72. PubMed ID: 31674269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Higher methylation subtype of malignant melanoma and its correlation with thicker progression and worse prognosis.
    Yamamoto Y; Matsusaka K; Fukuyo M; Rahmutulla B; Matsue H; Kaneda A
    Cancer Med; 2020 Oct; 9(19):7194-7204. PubMed ID: 32406600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current Trends in Circulating Biomarkers for Melanoma Detection.
    Huang N; Lee KJ; Stark MS
    Front Med (Lausanne); 2022; 9():873728. PubMed ID: 35492361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular, clinicopathological, and immune correlates of LAG3 promoter DNA methylation in melanoma.
    Fröhlich A; Sirokay J; Fietz S; Vogt TJ; Dietrich J; Zarbl R; Florin M; Kuster P; Saavedra G; Valladolid SR; Hoffmann F; Flatz L; Ring SS; Golletz C; Pietsch T; Strieth S; Brossart P; Gielen GH; Kristiansen G; Bootz F; Landsberg J; Dietrich D
    EBioMedicine; 2020 Sep; 59():102962. PubMed ID: 32861198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.